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Background:  Interleukin (IL)-33 is the most recently described member of the IL-1 family and is a ligand of the ST2 receptor. Recently IL-33 was 
shown to induce angiogenesis, vascular permeability and inflammatory activation in endothelial cells (EC). A possible influence of IL-33 on pro-
inflammatory cytokine in human cardiac and smooth muscle cells (SMC) was never studied before. 
Methods:  Human adult cardiac myocytes (HACM), human adult cardiac fibroblasts (HACF), or human coronary artery EC (HCAEC) and SMC 
(HCASMC) were isolated from human hearts or pieces of coronary arteries obtained from patients undergoing heart transplantation. Human 
umbilical vein EC (HUVEC) were isolated from fresh umbilical cords. Such cells were treated with recombinant human IL-33. IL-6, IL-8 and MCP-1 
proteins were measured by specific ELISAs. Specific mRNA level was determined by real-time PCR. Quantitation of NF-κB in nuclear extracts was also 
performed. IL-33 mRNA expression was studied in human carotid endaterectomy specimens from 15 symptomatic patients. 
Results:  HCAEC, HUVEC, HCASMC, HACM and HACF expressed ST2 receptor on the level of specific mRNA. IL-33 significantly increased IL-6, IL-8 
and MCP-1 protein production in both types of EC, but not in SMC, cardiac myocytes or fibroblasts. The effect of IL-33 on pro-inflammatory protein 
production was dose-dependent. IL-33 up-regulated also IL-6, IL-8 and MCP-1 mRNA level in HCAEC and HUVEC, but not in HCASMC, HACM or HACF. 
IL-33 at 100ng/mL induced translocation of NF-κB p50 and p65 subunits to the nucleus in HCAEC and HUVEC. IL-33 mRNA was present in human 
carotid atherosclerotic plaques. 
Conclusion:  We found that IL-33, a novel member of the IL-1 family of cytokines, is expressed in human atherosclerotic lesion and is an inducer of 
IL-6, IL-8 and MCP-1 production in human endothelial cells from both coronary artery and umbilical vein, but not in smooth muscle or cardiac cells. 
Such differential effect of IL-33 on these pro-inflammatory cytokines production could be, at least in part, the explanation for previously described 
different roles of this novel cytokine during inflammatory, allergic, or cardiovascular pathologies.
